Stock Alert: Windtree Therapeutics Jumps 22% As FDA Accepts IND Application For COVID-19 Treatment

Stock Alert: Windtree Therapeutics Jumps 22% As FDA Accepts IND Application For COVID-19 Treatment

RTTNews

Published

Shares of Windtree Therapeutics, Inc. (WINT) are gaining over 22% on Tuesday morning after the company said FDA accepted its IND application for a phase 2 trial studying KL4 Surfactant in acute lung injury in adults with COVID-19.

Full Article